Voloridge Investment Management, LLC Ab Cellera Biologics Inc. Transaction History

Voloridge Investment Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$4.29 - $5.97 $57,691 - $80,284	13,448 New	13,448 $60,000
Q2 2023 Aug 14, 2023	SELL	$5.66 - $7.59 $158,032 - $211,920	-27,921 Reduced 22.29%	97,323 $628,000
Q1 2023 May 15, 2023	BUY	$7.31 - $11.18 $915,533 - $1.4 Million	125,244 New	125,244 $944,000
Q2 2022 Aug 15, 2022	BUY	$5.72 - $10.65 $380,517 - $708,480	66,524 Added 51.22%	196,406 $2.09 Million
Q1 2022 May 16, 2022	BUY	$7.46 - $14.14 $968,919 - $1.84 Million	129,882 New	129,882 $1.27 Million
Q3 2021 Nov 15, 2021	SELL	$14.85 - $21.34 $2.59 Million - $3.72 Million	-174,428 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$20.19 - $34.17 $3.52 Million - $5.96 Million	174,428 New	174,428 $3.84 Million

153

109M

153K

194K

Ticker ABCL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 285,139,008
Market Cap $787M
Description
AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Voloridge Investment Management, LLC with notifications on news.